Zymeworks Inc. Balance Sheet
ZYME / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Zymeworks Inc. had $347M in total assets and $269M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41.2M | $66.1M | $157.6M | $400.9M | $201.9M | - |
| Accounts Receivable | $4.6M | $55.8M | $19.5M | $33.4M | $15.6M | - |
| Current Assets | $248.8M | $300.5M | $412.9M | $544.7M | $288.2M | - |
| PP&E (Net) | $15.5M | $17.6M | $19.8M | $24.7M | $22.8M | - |
| Goodwill | $12.0M | $12.0M | $12.0M | $12.0M | $12.0M | - |
| Total Assets | $346.5M | $463.1M | $580.9M | $648.7M | $389.1M | - |
| Current Liabilities | $42.3M | $88.3M | $55.8M | $95.6M | $71.9M | - |
| Shareholders' Equity | $268.5M | $338.8M | $464.8M | $409.9M | $249.1M | $409.9M |